1-(3-Methoxypropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 25g

4-cyclopropyl-1-phenyl-1,6-dihydro-7H-pyrazolo[3,4-d]pyridazin-7-one, 95.0%, 500mg

5-(2-methylpropyl)-1,3-oxazole-4-carboxylic acid, 95.0%, 250mg

N-Boc-N-(Phenylsulfonylmethyl)-hydroxylamine, 97.0%, 250mg

Fmoc-(R)-3-Amino-3-(3-methoxyphenyl)pr opionic acid, 97%, 100mg

2-(2,4-Dichloro-5-fluorophenyl)oxirane, 98%, 1g

3-Bromofluoranthene>98.0%(GC)1g

2-Chloro-6-fluoroacetophenone, 97.0%, 10g

2-Amino-6-chloro-4-nitrophenol, 95.0%, 500g

Placas de soporte posición estable, 200 mm, 315 mm, 1 Pieza

4-(3-Aminophenyl)-2-methyl-3-butyn-2-ol>98.0%(GC)(T)5g

OFLOXACIN, 95%, 25g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrazole, 95.0%, 100mg